Analystreport

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $51.00 to $40.00. They now have a "buy" r

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com